Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction
NCT: NCT06068959 · COMPLETED
Brief Summary
These studies aim to validate the effects of photobiomodulation using clusters of 850nm LEDs (infrared) and 630nm LEDs (red); in pain and cervical and mandibular mobility in patients with TMD. It is a randomized, controlled, and blind clinical trial, which will consist of n= 36, of both genders, with ages ranging from 18 to 45 years, divided into 2 groups: Group 1 Red and infrared LED cluster, Group 2 placebo. The areas where they will receive photobiomodulation will be the TMJ area, masseter muscles, temporal muscles, scalenes, and trapezius. 6 non-consecutive sessions will be performed over 2 weeks. Diagnostic Criteria for Temporomandibular Disorders - DC/TMD will be used to determine TMD and validate participants. To validate the mandibular range of motion (ADM) a pachymeter will be used and for the cervical ADM a goniometer (fleximeter). The pain will be validated using the visual analog scale-VAS. All participants will be evaluated after the first therapeutic intervention, and again at the end, following the same validation procedures used initially.
Frequently Asked Questions
What is Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction?
Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction is a clinical trial registered under NCT06068959. Current status: COMPLETED.
What is the status of NCT06068959?
The current status of NCT06068959 (Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction) is: COMPLETED.
When did Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction start?
Photobiomodulation on Pain in Patients With Temporomandibular Dysfunction started on 2024-02-29.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.